Abridge, an AI startup automating medical notes, has secured a $300 million Collection E at a $5.3 billion valuation, in line with the Wall Road Journal. The spherical, led by Andreessen Horowitz with participation from Khosla Ventures, follows the corporate’s $250 million February fundraise at a $2.75 billion valuation.
The 7-year-old Abridge is extensively thought of to be the chief within the more and more crowded AI-powered medical scribe market, largely as a consequence of its early entry and integration with Epic Programs, the dominant well being report software program.
In Q1, Abridge reached $117 million in contracted annual recurring income (a metric that features all signed recurring contacts, together with from clients which have nonetheless not been onboarded), The Data reported final month.
Together with the fundraise, Abridge introduced that it’s increasing into changing medical notes from affected person appointments into AI-powered medical codes, an providing that makes the corporate straight aggressive with startups like CodaMetrix and a characteristic from its companion Epic Programs.
Abridge, which was based by heart specialist Shiv Rao, claims that its AI scribe know-how is utilized by over 150 of the biggest well being methods within the U.S.
Keep forward of the curve with Enterprise Digital 24. Discover extra tales, subscribe to our e-newsletter, and be a part of our rising neighborhood at nextbusiness24.com
